BUSINESS
DOW REARRANGES A KEY PORTFOLIO
A change in strategy will see 'market-facing' businesses dispersed
MICHAEl MCCOY
Dow Chemical is changing the way it approaches its "market-facing" portfolio, a family of high-value, end-market-oriented businesses that the company considers key to its future growth.
|
 |
|
Wood
DOW PHOTO |
|
 |
|
Gross
PHOTO BY MICHAEL MCCOY
|
In conjunction with the retirement of Ed F. Gambrell, 59, president of the market-facing businesses group, Dow is disbanding the portfolio and giving responsibility to other senior executives.
Dow Automotive, the largest of the market-facing units, with about $1 billion in annual sales, will become part of Dow's thermosets business, headed by Robert L. Wood. The market-facing advanced electronic materials unit, which includes SiLK semiconductor resins and Lumation polymeric light-emitting diodes, will fall under David E. Kepler, Dow's chief information officer and vice president for e-business.
Richard M. Gross, vice president for R&D, will assume responsibility for the new business activities now under Gambrell. These include industrial biotechnology, pharmaceutical technologies, Dow's new business growth board, and its biotechnology steering committee.
A year ago, Gambrell told C&EN that the market-facing businesses were grouped together to nurture capabilities distinct from those needed to run Dow's core commodity businesses (C&EN, June 18, 2001, page 21).
Today, though, company representatives say many of the market-facing business are better established and will benefit from ties to Dow's traditional "asset-based" businesses. Dow Automotive, for example, is a big consumer of polyurethanes made by Wood's thermosets business. And in the case of new business development efforts, Dow expects the shift to Gross's leadership to improve synergy with R&D. |